Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Comment by Frogger2on Dec 03, 2014 11:49am
249 Views
Post# 23190170

RE:RE:RE:RE:RE:RE:News

RE:RE:RE:RE:RE:RE:NewsYank, I completely disagree with your comments.
 
First of all, where did find the information to support your conclusion regarding current shareholder sentiment? There are 167M shares outstanding, have you accounted for all shareholders? Please do not tell me that you base your conclusion from this BB!

The stock is speculative of course, we currently do not have income. What we do have is a successful phase III with amazing results. This along with a solid and well organized management team solely focused on approval provide a more likely positive than negative outcome.

The SP is stagnant and I think will be until we start to see milestones in addition to the BLA filing completed,  these (below) were indicated in the companies update Dec. 1st
 “In parallel, Telesta expects to conclude their third party assessment of the market opportunity for MCNA, in the United States, in the weeks to come.  This market assessment, where qualitative and quantitative primary market research was conducted with payers (managed care organizations/decision makers both from the private and public sector) and urologists (community urologists and key opinion leaders), will address issues such as market size, pricing/pricing strategy and market access context/reimbursement potential for MCNA.  These data will be key in assisting Telesta to make informed decisions concerning overall market potential and optimal licensing/partnering and/or commercial development strategy”

The company hit the restart button just one year ago. Over the past year the company has been focused on getting the business in order and now truly does have a focused and definitive plan in place. I believe we will see more positive IR, public attention and positive stock movement as we move closer to BLA submission and the completion of milestones quoted above.

My belief is that the shareholder base is passionate about this investment but were completely frustrated and continually disappointed by previous management. Dr. Berendt and team have done a great job in getting business in order and establishing new life and excitement.

Your comment regarding a 50 to 60 cent buyout offer is possible, but I would be surprised if anyone would consider this at this point and I’m sure the BOD would not endorse this. I believe we see an uptick in SP starting in Q1 2015.
<< Previous
Bullboard Posts
Next >>